Inhibitors of antigen presentation by MHC class II molecules and methods of use thereof

Details for Australian Patent Application No. 2004212954 (hide)

Owner Provid Pharmaceuticals, Inc.

Inventors Olson, Gary L.; Self, Christopher R.; Cook, Charles M.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2004212954

PCT Pub. Number WO2004/073625

Priority 60/447,949 14.02.03 US

Filing date 13 February 2004

Wipo publication date 2 September 2004

Acceptance publication date 17 July 2008

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

C07K 7/06 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 7/08 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

Event Publications

15 September 2005 PCT application entered the National Phase

  PCT publication WO2004/073625 Priority application(s): WO2004/073625

17 July 2008 Application Accepted

  Published as AU-B-2004212954

13 November 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004212957-Novel compounds

2004212953-Contraceptive methods and compositions related to proteasomal interference